Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293149970> ?p ?o ?g. }
- W4293149970 abstract "Although several antibody fragments and antibody fragment-fusion proteins produced in Escherichia coli (E. coli) are approved as therapeutics for various human diseases, a full-length monoclonal or a bispecific antibody produced in E. coli has not yet been approved. The past decade witnessed substantial progress in expression of full-length antibodies in the E. coli cytoplasm and periplasm, as well as in cell-free expression systems. The equivalency of E. coli-produced aglycosylated antibodies and their mammalian cell-produced counterparts, with respect to biochemical and biophysical properties, including antigen binding, in vitro and in vivo serum stability, pharmacokinetics, and in vivo serum half-life, has been demonstrated. Extensive engineering of the Fc domain of aglycosylated antibodies enables recruitment of various effector functions, despite the lack of N-linked glycans. This review summarizes recent research, preclinical advancements, and clinical development of E. coli-produced aglycosylated therapeutic antibodies as monoclonal, bispecific, and antibody-drug conjugates for use in autoimmune, oncology, and immuno-oncology areas.Abbreviations: ADA Anti-drug antibody; ADCC Antibody-dependent cellular cytotoxicity; ADCP Antibody-dependent cellular phagocytosis; ADC Antibody-drug conjugate; aFc Aglycosylated Fc; AMD Age-related macular degeneration aTTP Acquired thrombotic thrombocytopenic purpura; BCMA B-cell maturation antigen; BLA Biologics license application; BsAb Bispecific antibody; C1q Complement protein C1q; CDC Complement-dependent cytotoxicity; CDCC Complement-dependent cellular cytotoxicity; CDCP Complement-dependent cellular phagocytosis; CEX Cation exchange chromatography; CFPS Cell-free protein expression; CHO Chinese Hamster Ovary; CH1-3 Constant heavy chain 1-3; CL Constant light chain; DLBCL Diffuse large B-cell lymphoma; DAR Drug antibody ratio; DC Dendritic cell; dsFv Disulfide-stabilized Fv; EU European Union; EGFR Epidermal growth factor receptor; E. coli Escherichia coli; EpCAM Epithelial cell adhesion molecule; Fab Fragment antigen binding; FACS Fluorescence activated cell sorting; Fc Fragment crystallizable; FcRn Neonatal Fc receptor; FcɣRs Fc gamma receptors; FDA Food and Drug Administration; FL-IgG Full-length immunoglobulin; Fv Fragment variable; FolRαa Folate receptor alpha; gFc Glycosylated Fc; GM-CSF Granulocyte macrophage-colony stimulating factor; GPx7 Human peroxidase 7; HCL Hairy cell leukemia; HIV Human immunodeficiency virusl; HER2 Human epidermal growth factor receptor 2; HGF Hepatocyte growth factor; HIC Hydrophobic interaction chromatography; HLA Human leukocyte antigen; IBs Inclusion bodies; IgG1-4 Immunoglobulin 1-4; IP Intraperitoneal; ITC Isothermal titration calorimetry; ITP Immune thrombocytopenia; IV Intravenous; kDa Kilodalton; KiH Knob-into-Hole; mAb Monoclonal antibody; MAC Membrane-attack complex; mCRC Metastatic colorectal cancer; MM Multipl myeloma; MOA Mechanism of action; MS Mass spectrometry; MUC1 Mucin 1; MG Myasthenia gravis; NB Nanobody; NK Natural killer; nsAA Nonstandard amino acid; NSCLC Non-small cell lung cancer; P. aeruginosa Pseudomonas aeruginosa; PD-1 Programmed cell death 1; PD-L1 Programmed cell death-ligand 1; PDI Protein disulfide isomerase; PECS Periplasmic expression cytometric screening; PK Pharmacokinetics; P. pastoris Pichia pastoris; PTM Post-translational modification; Rg Radius of gyration; RA Rheumatoid arthritis; RT-PCR Reverse transcription polymerase chain reaction; SAXS Small angle X-ray scattering; scF Single chain Fv; SCLC Small cell lung cancer; SDS-PAGE Sodium dodecyl sulfate–polyacrylamide gel electrophoresis; SEC Size exclusion chromatography; SEED Strand-exchange engineered domain; sRNA Small regulatory RNA; SRP Signal recognition particle; T1/2 Half-life; Tagg Aggregation temperature; TCR T cell receptor; TDB T cell-dependent bispecific; TF Tissue factor; TIR Translation initiation region; Tm Melting temperature; TNBC Triple-negative breast cancer; TNF Tumor necrosis factor; TPO Thrombopoietin; VEGF Vascular endothelial growth factor; vH Variable heavy chain; vL Variable light chain; vWF von Willebrand factor; WT Wild type" @default.
- W4293149970 created "2022-08-27" @default.
- W4293149970 creator A5052255788 @default.
- W4293149970 date "2022-08-26" @default.
- W4293149970 modified "2023-09-30" @default.
- W4293149970 title "Full-length recombinant antibodies from<i>Escherichia coli</i>: production, characterization, effector function (Fc) engineering, and clinical evaluation" @default.
- W4293149970 cites W1239799147 @default.
- W4293149970 cites W1529809181 @default.
- W4293149970 cites W1562965396 @default.
- W4293149970 cites W1595328377 @default.
- W4293149970 cites W1820985264 @default.
- W4293149970 cites W1902650446 @default.
- W4293149970 cites W1915679696 @default.
- W4293149970 cites W1942301967 @default.
- W4293149970 cites W1967632373 @default.
- W4293149970 cites W1967697143 @default.
- W4293149970 cites W1973134700 @default.
- W4293149970 cites W1973718144 @default.
- W4293149970 cites W1973993524 @default.
- W4293149970 cites W1975076291 @default.
- W4293149970 cites W1977247859 @default.
- W4293149970 cites W1979816062 @default.
- W4293149970 cites W1980594873 @default.
- W4293149970 cites W1981392048 @default.
- W4293149970 cites W1982696245 @default.
- W4293149970 cites W1986197388 @default.
- W4293149970 cites W1990280024 @default.
- W4293149970 cites W1993530117 @default.
- W4293149970 cites W1995923662 @default.
- W4293149970 cites W1996040623 @default.
- W4293149970 cites W1999624685 @default.
- W4293149970 cites W2000693605 @default.
- W4293149970 cites W2005044790 @default.
- W4293149970 cites W2005519719 @default.
- W4293149970 cites W2006264959 @default.
- W4293149970 cites W2006768930 @default.
- W4293149970 cites W2008686474 @default.
- W4293149970 cites W2013993202 @default.
- W4293149970 cites W2014275356 @default.
- W4293149970 cites W2015027812 @default.
- W4293149970 cites W2016104946 @default.
- W4293149970 cites W2018355061 @default.
- W4293149970 cites W2018918678 @default.
- W4293149970 cites W2020274785 @default.
- W4293149970 cites W2029669166 @default.
- W4293149970 cites W2029684104 @default.
- W4293149970 cites W2031831504 @default.
- W4293149970 cites W2032552806 @default.
- W4293149970 cites W2034515273 @default.
- W4293149970 cites W2035070408 @default.
- W4293149970 cites W2035179120 @default.
- W4293149970 cites W2038876401 @default.
- W4293149970 cites W2039870425 @default.
- W4293149970 cites W2048560240 @default.
- W4293149970 cites W2050592674 @default.
- W4293149970 cites W2053175240 @default.
- W4293149970 cites W2057936669 @default.
- W4293149970 cites W2059992550 @default.
- W4293149970 cites W2060204419 @default.
- W4293149970 cites W2063136144 @default.
- W4293149970 cites W2068861782 @default.
- W4293149970 cites W2071979631 @default.
- W4293149970 cites W2074948867 @default.
- W4293149970 cites W2075901113 @default.
- W4293149970 cites W2077069177 @default.
- W4293149970 cites W2078624174 @default.
- W4293149970 cites W2082874134 @default.
- W4293149970 cites W2083545980 @default.
- W4293149970 cites W2085206766 @default.
- W4293149970 cites W2091513759 @default.
- W4293149970 cites W2092638671 @default.
- W4293149970 cites W2092900379 @default.
- W4293149970 cites W2098346284 @default.
- W4293149970 cites W2104173785 @default.
- W4293149970 cites W2105300484 @default.
- W4293149970 cites W2105330984 @default.
- W4293149970 cites W2106915248 @default.
- W4293149970 cites W2110272381 @default.
- W4293149970 cites W2114987260 @default.
- W4293149970 cites W2116894955 @default.
- W4293149970 cites W2121107218 @default.
- W4293149970 cites W2121746009 @default.
- W4293149970 cites W2123412929 @default.
- W4293149970 cites W2125519805 @default.
- W4293149970 cites W2138820253 @default.
- W4293149970 cites W2143586703 @default.
- W4293149970 cites W2146054033 @default.
- W4293149970 cites W2154515402 @default.
- W4293149970 cites W2156366212 @default.
- W4293149970 cites W2158637103 @default.
- W4293149970 cites W2161010036 @default.
- W4293149970 cites W2165496566 @default.
- W4293149970 cites W2166420822 @default.
- W4293149970 cites W2202982905 @default.
- W4293149970 cites W2253053879 @default.
- W4293149970 cites W2284248566 @default.
- W4293149970 cites W2289658572 @default.
- W4293149970 cites W2329542327 @default.
- W4293149970 cites W2342299171 @default.
- W4293149970 cites W2342713518 @default.